Hedge-fund manager Boaz Weinstein isn’t backing down in his uphill battle against the $300 billion U.K. investment-trust ...

The Trump administration's pledge to contain long-term U.S. Treasury yields has strengthened bond market expectations that a ...

Some traders are betting regulators may soon focus on a review of the Supplementary Leverage Ratio (SLR), a rule requiring ...

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

In a report released today, Tom Sykes from Deutsche Bank maintained a Buy rating on Unilever (ULVR – Research Report), with a price target of ...

Investing.com -- The dot com bubble of the late 1990s was a period of extraordinary growth and speculation in technology ...

The imposition of tariffs on steel and aluminum imports has resurfaced as a potential economic disruptor, raising concerns over inflationary pressures in the United States.  As per Deutsche Bank ...

Albemarle (NYSE:ALB – Free Report) had its target price reduced by BMO Capital Markets from $150.00 to $140.00 in a research ...

Royal Bank of Canada upgraded shares of Heineken (OTCMKTS:HEINY – Free Report) from an underperform rating to a sector perform rating in a research note released on Wednesday, Marketbeat Ratings ...

Indian non-bank lender Shriram Finance has struck a US$500mn agreement with a group of banks and Italy’s export credit agency ...

Inflation, unemployment and PMI data next week will provide the next piece of the puzzle. US: Business inventories, Empire ...

Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...